Curi RMB Capital’s Usana Health Sciences USNA Stock Holding History

Curi RMB Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,000	Closed	-$347K	–	694
2020 Q1	$347K	Buy	6,000 +76	+1%	+$5.29K	0.02%	464
2019 Q4	$465K	Buy	+5,924	New	+$436K	0.01%	461

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Curi RMB Capital's USNA Position: Q2 2020 in Review

Curi RMB Capital sold out of Usana Health Sciences (USNA) in Q2 2020, closing a stake of 6,000 shares — an estimated $347K sold.

Curi RMB Capital first reported a position in USNA in Q4 2019 and held it in 2 quarters. The position peaked at $465K in Q4 2019. 192 funds tracked by Wall St. Rank hold USNA as of Q2 2020.

Curi RMB Capital reported no remaining Usana Health Sciences position as of Q2 2020 after selling out during the quarter.
Curi RMB Capital sold 6,000 Usana Health Sciences shares in Q2 2020, an estimated $347K.
Curi RMB Capital first reported a position in Usana Health Sciences in Q4 2019 and held it in 2 quarters.
Curi RMB Capital's Usana Health Sciences position peaked at $465K in Q4 2019.
192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2020.

Based on Curi RMB Capital's 13F filing for Q2 2020, filed 5 Aug 2020.